María Angeles Espinosa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Interests
María Angeles Espinosa has a total of 89 co-authors. Here are the top co-authors by number of shared publications:
- Pablo Garcia-Pavia
Department of Cardiology, Hospital Universitario Puerta de Hierro Majadahonda, IDIPHISA , Manuel de Falla, 2, Madrid 28222
3 shared publications - Tomás Ripoll-Vera
Health Research Institute of the Balearic Islands (IDISBA) , Palma, Balearic Islands
3 shared publications - Ana García-Álvarez
CIBER Cardiovascular, Instituto de Salud Carlos III, Madrid, Spain (N.R.-L., N.M.-A., C.G.G., M.G.M., G.C., C.M.-E., J.M.G.-P., G.C.V., V.E.B., A.G.-Á., E.Z., E.R.G., M.G.D., J.F.R.-P., A.d.M., M.Á.E.C., P.G.-P., J.G.M.).
2 shared publications - Andrea Di Marco
Department of Cardiology, Bellvitge University Hospital, Hospitalet de Llobregat, Barcelona, Spain; Bioheart Group, Cardiovascular, Respiratory and Systemic Diseases and Cellular Aging Program, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares, CIBER-CV, Madrid, Spain
2 shared publications - Connie R. Bezzina
Amsterdam Cardiovascular Sciences, Cardiomyopathy and Arrhythmia, Amsterdam, Netherlands
2 shared publications Cristina Gómez-González
CIBER Cardiovascular, Instituto de Salud Carlos III , Calle Monforte de Lemos, 3–5, Pabellón 11, 28029 Madrid
2 shared publications
Latest Publications
- Open Access
- 10 November 2026
- Published by Oxford University Press (OUP) in European Heart Journal
Incremental yield of genetic retesting in hypertrophic cardiomyopathy
Background and Aims: Modern genetic testing in hypertrophic cardiomyopathy (HCM) includes newly described HCM-associated genes and full intronic regions of certain classic sarcomeric genes. This study evaluated genetic retesting in HCM patients with a prior negative test and identified predictors of a positive result to guide retesting. Methods: This multicentre study included patients with HCM who previously had negative next-generation sequencing (NGS)-based genetic testing at four centres. Subjects were retested using an updated NGS-based HCM panel. Results: Of 508 retested HCM patients (median age 70 years; 66.9% male; median maximal left ventricular wall thickness 18 mm; median interval from initial genetic test 6.6 years), 46 (9%) had 48 HCM-related variants: 14 in new HCM-associated genes, 3 in deep intronic MYBPC3 regions, 18 intermediate-effect variants, and 13 (8 reclassified) in classic HCM-associated genes. In multivariable analysis, the presence of late gadolinium enhancement (LGE) [odds ratio (OR) 3.52; 95% confidence interval (CI) 1.38–10.25], the Mayo HCM score (OR 1.46 per 1 point increase; 95% CI 1.08–2.01), and the Toronto HCM score (OR 1.18 per 1 point increase; 95% CI 1.08–1.30) were independent predictors of detecting HCM-related variants at retesting. The diagnostic yields in patients with LGE and a high Toronto score (≥13 points), and with LGE and a high Mayo score (≥4 points), were 80% and 50%, respectively. Conclusions: In patients with HCM and prior negative genetic testing, retesting identified HCM-related variants in 9% of individuals, allowing counselling and risk stratification. Late gadolinium enhancement, combined with the Mayo and Toronto scores, may be used to guide which patients should be prioritized for genetic retesting.
- 10 November 2026
- Published by Oxford University Press (OUP) in European Heart Journal
Open AccessIncremental yield of genetic retesting in hypertrophic cardiomyopathy
Background and Aims: Modern genetic testing in hypertrophic cardiomyopathy (HCM) includes newly described HCM-associated genes and full intronic regions of certain classic sarcomeric genes. This study evaluated genetic retesting in HCM patients with a prior negative test and identified predictors of a positive result to guide retesting. Methods: This multicentre study included patients with HCM who previously had negative next-generation sequencing (NGS)-based genetic testing at four centres. Subjects were retested using an updated NGS-based HCM panel. Results: Of 508 retested HCM patients (median age 70 years; 66.9% male; median maximal left ventricular wall thickness 18 mm; median interval from initial genetic test 6.6 years), 46 (9%) had 48 HCM-related variants: 14 in new HCM-associated genes, 3 in deep intronic MYBPC3 regions, 18 intermediate-effect variants, and 13 (8 reclassified) in classic HCM-associated genes. In multivariable analysis, the presence of late gadolinium enhancement (LGE) [odds ratio (OR) 3.52; 95% confidence interval (CI) 1.38–10.25], the Mayo HCM score (OR 1.46 per 1 point increase; 95% CI 1.08–2.01), and the Toronto HCM score (OR 1.18 per 1 point increase; 95% CI 1.08–1.30) were independent predictors of detecting HCM-related variants at retesting. The diagnostic yields in patients with LGE and a high Toronto score (≥13 points), and with LGE and a high Mayo score (≥4 points), were 80% and 50%, respectively. Conclusions: In patients with HCM and prior negative genetic testing, retesting identified HCM-related variants in 9% of individuals, allowing counselling and risk stratification. Late gadolinium enhancement, combined with the Mayo and Toronto scores, may be used to guide which patients should be prioritized for genetic retesting.
- 3 November 2026
- Published by Wolters Kluwer Health in Circulation
- Vol. 154 (18) , 1791-1805
Arrhythmic Risk Stratification According to LGE Corridors and Genetics in Nonischemic Dilated Cardiomyopathy
BACKGROUND: Fibrosis assessed through late gadolinium enhancement (LGE) in cardiac magnetic resonance imaging and genetics have emerged as risk markers of ventricular arrhythmias in nonischemic dilated cardiomyopathy. Conduction corridors detected within LGE (ie, LGE corridors) have been associated with ventricular arrhythmias in ischemic cardiomyopathy. This study sought to evaluate major ventricular arrhythmic events (MVAs) according to the presence of LGE corridors combined with high-risk genotypes (HRGs) in nonischemic dilated cardiomyopathy. METHODS: We studied consecutive patients with nonischemic dilated cardiomyopathy from 22 European centers who had undergone genetic testing and cardiac magnetic resonance imaging. RESULTS: Among 925 patients (mean age, 54.5 years [interquartile range, 43.7–63.9 years]; 64% men; mean left ventricular ejection fraction, 37.6% [26.9%–44.8%]; LGE in 24.3%), LGE corridors were present in 160 patients (17.3%), and HRG in 119 (12.9%). After a median follow-up of 5.4 years (interquartile range, 3.3–7.7), 95 patients (10.3%) experienced an MVA. In multivariable competing-risk analysis adjusted for left ventricular ejection fraction and extent of LGE, the number of LGE corridors and HRGs were independently associated with MVA (subdistribution hazard ratio, 1.25 [95% CI, 1.11–1.42]; P P =0.003, respectively). An optimal cutoff of ≥4 LGE corridors predicted MVA. A stepwise risk stratification algorithm to predict MVA integrating LGE, the presence of ≥4 LGE corridors, and HRG outperformed left ventricular ejection fraction ≤35%–based classification proposed in guidelines (5-year time-dependent area under the curve, 0.72 [95% CI, 0.65–0.78] versus 0.57 [95% CI, 0.51–0.64]; P =0.001), showing a progressive increase in arrhythmic risk across categories (Gray test P <0.001), and allowing clinically meaningful arrhythmic risk classification. CONCLUSIONS: LGE corridors and HRGs provide additive value for arrhythmic risk stratification in patients with nonischemic dilated cardiomyopathy. These findings support MVA multiparametric prediction over the traditional left ventricular ejection fraction ≤35% threshold.
- 3 November 2026
- Published by Wolters Kluwer Health in Circulation
- Vol. 154 (18) , 1791-1805
Arrhythmic Risk Stratification According to LGE Corridors and Genetics in Nonischemic Dilated Cardiomyopathy
BACKGROUND: Fibrosis assessed through late gadolinium enhancement (LGE) in cardiac magnetic resonance imaging and genetics have emerged as risk markers of ventricular arrhythmias in nonischemic dilated cardiomyopathy. Conduction corridors detected within LGE (ie, LGE corridors) have been associated with ventricular arrhythmias in ischemic cardiomyopathy. This study sought to evaluate major ventricular arrhythmic events (MVAs) according to the presence of LGE corridors combined with high-risk genotypes (HRGs) in nonischemic dilated cardiomyopathy. METHODS: We studied consecutive patients with nonischemic dilated cardiomyopathy from 22 European centers who had undergone genetic testing and cardiac magnetic resonance imaging. RESULTS: Among 925 patients (mean age, 54.5 years [interquartile range, 43.7–63.9 years]; 64% men; mean left ventricular ejection fraction, 37.6% [26.9%–44.8%]; LGE in 24.3%), LGE corridors were present in 160 patients (17.3%), and HRG in 119 (12.9%). After a median follow-up of 5.4 years (interquartile range, 3.3–7.7), 95 patients (10.3%) experienced an MVA. In multivariable competing-risk analysis adjusted for left ventricular ejection fraction and extent of LGE, the number of LGE corridors and HRGs were independently associated with MVA (subdistribution hazard ratio, 1.25 [95% CI, 1.11–1.42]; P P =0.003, respectively). An optimal cutoff of ≥4 LGE corridors predicted MVA. A stepwise risk stratification algorithm to predict MVA integrating LGE, the presence of ≥4 LGE corridors, and HRG outperformed left ventricular ejection fraction ≤35%–based classification proposed in guidelines (5-year time-dependent area under the curve, 0.72 [95% CI, 0.65–0.78] versus 0.57 [95% CI, 0.51–0.64]; P =0.001), showing a progressive increase in arrhythmic risk across categories (Gray test P <0.001), and allowing clinically meaningful arrhythmic risk classification. CONCLUSIONS: LGE corridors and HRGs provide additive value for arrhythmic risk stratification in patients with nonischemic dilated cardiomyopathy. These findings support MVA multiparametric prediction over the traditional left ventricular ejection fraction ≤35% threshold.
- Open Access
- 4 August 2026
- Published by Wolters Kluwer Health in Circulation
- Vol. 154 (5) , 440-453
Left Ventricular Hypertrabeculation and Prognosis in Dilated Cardiomyopathy
BACKGROUND: Left ventricular (LV) hypertrabeculation, formerly termed LV noncompaction, is a heterogeneous myocardial entity linked to adverse cardiovascular outcomes. This study evaluated embolic risk in patients with dilated cardiomyopathy (DCM) according to the presence of hypertrabeculation and examined its prevalence and prognostic relevance across DCM genotypes. METHODS: Clinical data from 1160 patients with DCM evaluated by cardiac magnetic resonance imaging and genetic testing (n=997 [86%]) were collected from 22 international centers. End points included embolic events, advanced heart failure events, and major ventricular arrhythmias. RESULTS: LV hypertrabeculation was identified in 354 patients (30.5%) by fractal analysis and in 343 (29.7%) according to Petersen criteria, with good concordance. After a median follow-up of 5.1 years (interquartile range, 2.8–7.4), embolic events occurred in 37 patients (3.2%), advanced heart failure in 62 (5.3%), and major ventricular arrhythmias in 136 (11.7%). Hypertrabeculation was not associated with increased embolic risk (hazard ratio, 1.5 [95% CI, 0.75–3.00]), even among patients in sinus rhythm with LV ejection fraction ≤40% (hazard ratio, 1.89 [95% CI, 0.7–5.5]). In contrast, atrial fibrillation and reduced LV ejection fraction were associated with embolic events (both P TTN (38%), and genotype-negative status (33%), and the lowest prevalence observed among those with variants in cytoskeletal/Z-disk (7%) and nuclear envelope (5%) genes. Hypertrabeculation was not associated with adverse outcomes within any genotype. CONCLUSIONS: Although LV hypertrabeculation is common in DCM, it is not associated with worse outcomes and should not prompt differential clinical management. The embolic risk in patients with DCM and hypertrabeculation is low, including in those with reduced LV ejection fraction without atrial fibrillation, and does not support prophylactic anticoagulation in these patients.
- 4 August 2026
- Published by Wolters Kluwer Health in Circulation
- Vol. 154 (5) , 440-453
Open AccessLeft Ventricular Hypertrabeculation and Prognosis in Dilated Cardiomyopathy
BACKGROUND: Left ventricular (LV) hypertrabeculation, formerly termed LV noncompaction, is a heterogeneous myocardial entity linked to adverse cardiovascular outcomes. This study evaluated embolic risk in patients with dilated cardiomyopathy (DCM) according to the presence of hypertrabeculation and examined its prevalence and prognostic relevance across DCM genotypes. METHODS: Clinical data from 1160 patients with DCM evaluated by cardiac magnetic resonance imaging and genetic testing (n=997 [86%]) were collected from 22 international centers. End points included embolic events, advanced heart failure events, and major ventricular arrhythmias. RESULTS: LV hypertrabeculation was identified in 354 patients (30.5%) by fractal analysis and in 343 (29.7%) according to Petersen criteria, with good concordance. After a median follow-up of 5.1 years (interquartile range, 2.8–7.4), embolic events occurred in 37 patients (3.2%), advanced heart failure in 62 (5.3%), and major ventricular arrhythmias in 136 (11.7%). Hypertrabeculation was not associated with increased embolic risk (hazard ratio, 1.5 [95% CI, 0.75–3.00]), even among patients in sinus rhythm with LV ejection fraction ≤40% (hazard ratio, 1.89 [95% CI, 0.7–5.5]). In contrast, atrial fibrillation and reduced LV ejection fraction were associated with embolic events (both P TTN (38%), and genotype-negative status (33%), and the lowest prevalence observed among those with variants in cytoskeletal/Z-disk (7%) and nuclear envelope (5%) genes. Hypertrabeculation was not associated with adverse outcomes within any genotype. CONCLUSIONS: Although LV hypertrabeculation is common in DCM, it is not associated with worse outcomes and should not prompt differential clinical management. The embolic risk in patients with DCM and hypertrabeculation is low, including in those with reduced LV ejection fraction without atrial fibrillation, and does not support prophylactic anticoagulation in these patients.
- Open Access
Cardiac Stasis Imaging, Stroke and Silent Brain Infarcts in Patients with Non-Ischemic Dilated Cardiomyopathy
Background: Cardioembolic stroke is one of the most devastating complications of non-ischemic dilated cardiomyopathy (NIDCM). However, in clinical trials of primary prevention, the benefits of anticoagulation were hampered by the risk of bleeding. If indices of cardiac blood stasis account for the risk of stroke, they may be useful to individualize primary prevention treatments. Methods: We performed a cross-sectional study in patients with NIDCM and no history of atrial fibrillation (AF) from two sources: 1) a prospective enrollment of unselected patients with left ventricular (LV) ejection fraction R T ). The study was registered in ClinicalTrials.gov ( NCT03415789 ). Results: Of the 89 recruited patients, 18 showed a positive primary endpoint: 9 patients had a history stroke or TIA and another 9 were diagnosed with SBIs in the brain imaging. R T performed good to identify the primary endpoint (AUC (95% CI)= 0.75 (0.61-0.89), p= 0.001). A R T > 2.21 cycles showed a sensitivity of 0.88 (0.77-1.00) and specificity of 0.70 (0.10-0.81). When accounting only for identifying a history of stroke or TIA, AUC for R T was 0.92 (0.85-1.00) with and odds ratio= 7.2 (2.3 – 22.3) per cycle, p< 0.001. Conclusions: In patients with NIDCM in sinus rhythm, stasis imaging derived from echocardiographyis is closely related to the burden of stroke. Stasis imaging may be useful to address stroke risk in patients with systolic dysfunction.
Open AccessCardiac Stasis Imaging, Stroke and Silent Brain Infarcts in Patients with Non-Ischemic Dilated Cardiomyopathy
Background: Cardioembolic stroke is one of the most devastating complications of non-ischemic dilated cardiomyopathy (NIDCM). However, in clinical trials of primary prevention, the benefits of anticoagulation were hampered by the risk of bleeding. If indices of cardiac blood stasis account for the risk of stroke, they may be useful to individualize primary prevention treatments. Methods: We performed a cross-sectional study in patients with NIDCM and no history of atrial fibrillation (AF) from two sources: 1) a prospective enrollment of unselected patients with left ventricular (LV) ejection fraction R T ). The study was registered in ClinicalTrials.gov ( NCT03415789 ). Results: Of the 89 recruited patients, 18 showed a positive primary endpoint: 9 patients had a history stroke or TIA and another 9 were diagnosed with SBIs in the brain imaging. R T performed good to identify the primary endpoint (AUC (95% CI)= 0.75 (0.61-0.89), p= 0.001). A R T > 2.21 cycles showed a sensitivity of 0.88 (0.77-1.00) and specificity of 0.70 (0.10-0.81). When accounting only for identifying a history of stroke or TIA, AUC for R T was 0.92 (0.85-1.00) with and odds ratio= 7.2 (2.3 – 22.3) per cycle, p< 0.001. Conclusions: In patients with NIDCM in sinus rhythm, stasis imaging derived from echocardiographyis is closely related to the burden of stroke. Stasis imaging may be useful to address stroke risk in patients with systolic dysfunction.
- Open Access
- 20 July 2020
- Published by Universitat Autonoma de Barcelona in Educar
- Vol. 56 (2) , 297-314
La educación para el desarrollo y los derechos de la infancia: el papel de las agencias internacionales y el impacto de la formación en la transformación de los contextos
El objetivo del artículo es describir el papel que las agencias internacionales tienen en la educación para el desarrollo desde un enfoque de derechos de la infancia. Considerando, como uno de los principales hitos, la aprobación en 1989 de la Convención de las Naciones Unidas sobre los Derechos del Niño y estableciendo el bienestar infantil como base para la consecución de la Agenda 2030, se detalla una experiencia exitosa, el Programa Ciudades Amigas de la Infancia de UNICEF-Comité Español, y la evaluación del impacto del Programa de Formación de Postgrado en Derechos y Políticas Municipales de Infancia. Los resultados ponen de manifiesto que la formación mejora la estabilidad laboral, las competencias profesionales y el desarrollo de iniciativas integrales de infancia, pero también que no tiene un efecto tan positivo en el reconocimiento que las organizaciones otorgan a los profesionales. Se concluye acerca de la importancia de la formación como una potente herramienta en la transformación de los contextos socioeducativos.
- 20 July 2020
- Published by Universitat Autonoma de Barcelona in Educar
- Vol. 56 (2) , 297-314
Open AccessLa educación para el desarrollo y los derechos de la infancia: el papel de las agencias internacionales y el impacto de la formación en la transformación de los contextos
El objetivo del artículo es describir el papel que las agencias internacionales tienen en la educación para el desarrollo desde un enfoque de derechos de la infancia. Considerando, como uno de los principales hitos, la aprobación en 1989 de la Convención de las Naciones Unidas sobre los Derechos del Niño y estableciendo el bienestar infantil como base para la consecución de la Agenda 2030, se detalla una experiencia exitosa, el Programa Ciudades Amigas de la Infancia de UNICEF-Comité Español, y la evaluación del impacto del Programa de Formación de Postgrado en Derechos y Políticas Municipales de Infancia. Los resultados ponen de manifiesto que la formación mejora la estabilidad laboral, las competencias profesionales y el desarrollo de iniciativas integrales de infancia, pero también que no tiene un efecto tan positivo en el reconocimiento que las organizaciones otorgan a los profesionales. Se concluye acerca de la importancia de la formación como una potente herramienta en la transformación de los contextos socioeducativos.
- Open Access
- 24 April 2020
- Published by Servicio de Publicaciones de la Universidad Autonoma de Madrid in Revista Internacional de Educación para la Justicia Social
- Vol. 9 (3) , 245-258
Covid-19, Educación y Derechos de la Infancia en España
Las medidas adoptadas en el Real Decreto por el que se declara el estado de alarma para luchar contra la epidemia producida por el Covid-19 en España impactan de manera directa sobre niños, niñas y adolescentes. El objetivo de este artículo es analizar, en su primera parte, la compleja relación que existe entre el derecho a la protección de la salud, el derecho a la educación y los derechos de la infancia. La suspensión de la actividad docente presencial ha supuesto no solamente la posibilidad de que muchos niños y niñas vean ralentizados sus aprendizajes escolares, especialmente aquellos que proceden de entornos más vulnerables, sino también que dejen de estar protegidos y que pierdan la posibilidad de alcanzar unas mejores condiciones de vida, por el efecto positivo que la escuela tiene como herramienta de compensación de las desigualdades sociales. Parece, entonces, necesario que se aborde, en la segunda parte del artículo, una seria reflexión acerca de las condiciones y el momento en el que se debe volver a las aulas. Así como, sobre las medidas que se han de adoptar para garantizar la calidad y la equidad del sistema educativo teniendo en cuenta que la enfermedad seguirá estando presente en nuestras vidas y, por tanto, el riesgo de que se produzcan nuevos contagios. Disponer de un Plan Nacional de Digitalización; revisar el curriculum, y proporcionar programas de refuerzo son retos que enfrenta nuestro sistema educativo, pero que pueden convertirse en oportunidades para mejorar su calidad y equidad.
- 24 April 2020
- Published by Servicio de Publicaciones de la Universidad Autonoma de Madrid in Revista Internacional de Educación para la Justicia Social
- Vol. 9 (3) , 245-258
Open AccessCovid-19, Educación y Derechos de la Infancia en España
Las medidas adoptadas en el Real Decreto por el que se declara el estado de alarma para luchar contra la epidemia producida por el Covid-19 en España impactan de manera directa sobre niños, niñas y adolescentes. El objetivo de este artículo es analizar, en su primera parte, la compleja relación que existe entre el derecho a la protección de la salud, el derecho a la educación y los derechos de la infancia. La suspensión de la actividad docente presencial ha supuesto no solamente la posibilidad de que muchos niños y niñas vean ralentizados sus aprendizajes escolares, especialmente aquellos que proceden de entornos más vulnerables, sino también que dejen de estar protegidos y que pierdan la posibilidad de alcanzar unas mejores condiciones de vida, por el efecto positivo que la escuela tiene como herramienta de compensación de las desigualdades sociales. Parece, entonces, necesario que se aborde, en la segunda parte del artículo, una seria reflexión acerca de las condiciones y el momento en el que se debe volver a las aulas. Así como, sobre las medidas que se han de adoptar para garantizar la calidad y la equidad del sistema educativo teniendo en cuenta que la enfermedad seguirá estando presente en nuestras vidas y, por tanto, el riesgo de que se produzcan nuevos contagios. Disponer de un Plan Nacional de Digitalización; revisar el curriculum, y proporcionar programas de refuerzo son retos que enfrenta nuestro sistema educativo, pero que pueden convertirse en oportunidades para mejorar su calidad y equidad.
- 16 March 2019
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 21 (7) , 1095
Epicardial ablation for ventricular tachycardia in Freidreich’s ataxia cardiomyopathy
- 16 March 2019
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 21 (7) , 1095
Epicardial ablation for ventricular tachycardia in Freidreich’s ataxia cardiomyopathy
- 13 July 2018
- Published by Taylor & Francis in Early Child Development and Care
- Vol. 188 (11) , 1514-1527
The role of NGOs in the dissemination and implementation of positive parenting in Spain
This article chronologically reviews different contributions of the non-governmental organizations to the positive parenting initiative currently adopted in Spain. It starts with the theoretical framework adopted by UNICEF and the Oxford University researchers on the contribution of the International Agencies and NGOs to this subject that was implemented after the approval of the U.N. Convention on the Rights of the Child in 1989. These first proposals were directed to train parents according to the principle of ‘the best interest of the child’. The article follows with initiatives developed mainly by UNICEF, WHO and NGO such as Save the Children, after that, in middle and low income countries. In the OCDE countries positive parenting programmes were also promoted. More recently, following the adoption of Recommendation 19 (2006) of the Council of Europe, several NGOs have developed numerous projects about parenting support services and programmes. Also, some positive parenting programmes, that are carried out in specifically Spain, by International and National NGO, are analysed. To conclude, NGOs have significantly contributed to the development of positive parenting in Spain, frequently in collaboration with public organisms from regional, autonomic and state levels.
- 13 July 2018
- Published by Taylor & Francis in Early Child Development and Care
- Vol. 188 (11) , 1514-1527
The role of NGOs in the dissemination and implementation of positive parenting in Spain
This article chronologically reviews different contributions of the non-governmental organizations to the positive parenting initiative currently adopted in Spain. It starts with the theoretical framework adopted by UNICEF and the Oxford University researchers on the contribution of the International Agencies and NGOs to this subject that was implemented after the approval of the U.N. Convention on the Rights of the Child in 1989. These first proposals were directed to train parents according to the principle of ‘the best interest of the child’. The article follows with initiatives developed mainly by UNICEF, WHO and NGO such as Save the Children, after that, in middle and low income countries. In the OCDE countries positive parenting programmes were also promoted. More recently, following the adoption of Recommendation 19 (2006) of the Council of Europe, several NGOs have developed numerous projects about parenting support services and programmes. Also, some positive parenting programmes, that are carried out in specifically Spain, by International and National NGO, are analysed. To conclude, NGOs have significantly contributed to the development of positive parenting in Spain, frequently in collaboration with public organisms from regional, autonomic and state levels.